Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus

Vaccine

Volumn 26, Issue 46, 2008, Pages 5802-5807

  Li, Peng ^a   Zheng, Qi Sheng ^b   Wang, Qin ^c   Li, Yan ^d   Wang, En Xiu ^e   Liu, Jing Jun ^a   Cao, Rui Bing ^a   Chen, Pu Yan ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b National Veterinary Biological Medicine Engineering Research Center   (China)

^c China Institute of Veterinary Drug Control   (China)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokine; Epitope; Japanese encephalitis virus; Recombinant adenovirus

Indexed keywords

AMINO ACID; EPITOPE; GAMMA INTERFERON; INACTIVATED VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT ADENOVIRUS TEP PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SPLEEN CELL; STATISTICAL SIGNIFICANCE; SWINE; TH1 CELL; TH2 CELL; VIRUS INFECTION;

ADENOVIRIDAE; ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; BLOTTING, WESTERN; CYTOKINES; ENCEPHALITIS VIRUSES, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SWINE; TH1 CELLS; TH2 CELLS; VACCINES, SYNTHETIC;

EID: 53449099909     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.035     Document Type: Article

References (45)

1. Shope R.E. Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals. In: Schlesinger R.W. (Ed). The togaviruses (1980), Academic Press, New York 47-82
2. Vrati S., Giri R.K., Razdan A., and Malik P. Complete nucleotide sequence of an Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis. Am J Trop Med Hyg 61 (1999) 677-680
3. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome rganization, expression and replication. Annu Rev Microbiol 44 (1990) 649
4. Mason P.W., Dalrymple J.M., Gentry M.K., McCown J.M., Hoke C.H., Burke D.S., et al. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70 (1989) 2037-2049
5. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., et al. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73 (1999) 10137-10145
6. Wu S.-C., and Lin C.-W. Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Res 76 (2001) 59-69
7. Kolaska A.S., and Kulkarni-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes. Virology 261 (1999) 31-42
8. Seif S.A., Morita K., Matsuo S., Hasebe F., and Igarashi A. Finger mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system. Vaccine 13 (1995) 1515-1521
9. + cytotoxic T lymphocytes. Arch Virol 145 (2000) 523-534
10. Kutubuddin M., Kolaskar A.S., Galande S., Gore M.M., Ghosh S.N., and Banerjee K. Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis. West Nile and Dengue viruses. Mol Immunol 28 (1991) 149-154
11. Tsai T.F., Chang G.F., and Yu Y.X. Japanese encephalitis vaccines. In: Stanley A.P., and Oreustein W.A. (Eds). Vaccines. 3rd ed. (1999), Saunders, Philadelphia, PA 672-710
12. Andersen M.M., and Ronne T. Side-effects with Japanese encephalitis vaccine. Lancet 337 (1991) 1044
13. Plesner A.M., and Ronne T. Allergic mucocutaneous reactions to Japanese encehalitis vaccine. Vaccine 15 (1997) 1239-1243
14. Olszewska W., and Steward M.W. Nasal delivery of epitope-based vaccines. Adv Drug Deliv Rev 51 (2001) 161-171
15. Both G.W., Lockett L.J., Janardhana V., Edwards S.G., Bellamy A.R., Graham F.L., et al. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193 (1993) 940-950
16. Casimiro D.R., Tang A., Chen L., Fu T.M., Evans R.K., Davies M.E., et al. Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 77 (2003) 7663-7668
17. ImLer J.L. Adenovirus vectors as recombinant viral vaccines. Vaccine 13 (1995) 1143-1151
18. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 (2002) 331-335
19. Sharpe S., Fooks A., Lee J., Hayes K., Clegg C., and Cranage M. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses. Virology 293 (2002) 210-216
20. Zhao J., Lou Y., Pinczewski J., Malkevitch N., Aldrich K., Kalyanaraman V.S., et al. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine 21 (2003) 4022-4035
21. Lemiale F., Kong W.P., Akyurek L.M., Ling X., Huang Y., Chakrabarti B.K., et al. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 77 (2003) 10078-10087
22. Lubeck M.D., Davis A.R., Chengalvala M., Natuk R.J., Morin J.E., Molnar-Kimber K., et al. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 86 (1989) 6763-6767
23. Ge F., Qiu Y., Gao X., Yang Y., and Chen P. Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70. Vet Immunol Immunopathol 113 (2006) 288-296
24. Johnson M.P., Meitin C.A., Bender B.S., and Small Jr. P.A. Passive immune serum inhibits antibody response to recombinant vacinia virus. In: Ginsberg H., Brown F., Lerner R.A., and Chanock R.M. (Eds). Vaccines vol. 88 (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 189-192
25. Kaur R., and Vrati S. Development of a recombinant vaccine against Japanese encephalitis. J Neurovirol 9 (2003) 421-431
26. Jaiswal S., Khanna N., and Swaminathan S. Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol 77 (2003) 12907-12913
27. Fonseca B.A., Pincus S., Shope R.E., Paoletti E., and Mason P.W. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12 (1994) 279-285
28. Guirakhoo F., Weltzin R., Chambers T.J., Zhang Z.X., Soike K., Ratterree M., et al. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol 74 (2000) 5477-5485
29. Livingston P.G., Kurane I., Lai C.J., Bray M., and Ennis F.A. Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones. J Virol 68 (1994) 3283-3288
30. Jan L.R., Yang C.S., Henchal L.S., Sumiyoshi H., Summers P.L., Dubois D.R., et al. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein. Am J Trop Med Hyg 48 (1993) 412-423
31. Konishi E., Yamaoka M., Khin S.W., Kurane I., Takada K., and Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 73 (1999) 5527-5534
32. Pan C.H., Chen H.W., Huang H.W., and Tao M.H. Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J Virol 75 (2001) 11457-11463
33. Vos A., Neubert A., Pommerening E., Müller T., Döhner L., Neubert L., et al. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J Gen Virol 82 (2001) 2191-2197
34. Raikwar S.P., Malik P., Singh O., and Vrati S. Recombinant adenovirus synthesizing cell surface-anchored beta hCG induces bioneutralizing antibodies in rats. Gene 190 (1997) 197-202
35. Lemiale F., Kong W.P., Akyurek L.M., et al. Enhanced mucosal immune-oglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 77 (2003) 10078-10087
36. Konishi E., Ajiro N., Nukuzuma C., Mason P.W., and Kuranec I. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine 21 (2003) 3675-3683
37. Cote-Sierra J., Foucras G., and Guo L. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci USA 101 (2004) 3880-3885
38. Jelinek D.F., Splawski J.B., and Lipsky P.E. The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation. J Immunol 16 (1986) 925-932
39. Splawski J.B., McAnally L.M., and Lipsky P.E. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol 144 (1990) 562-569
40. Kovanen P.E., and Leonard W.J. Cytokine and immunodeficiency diseases: critical roles of the gamma (c)-dependent cytokines interleukins 2, 4, 7, 9, 15 and 21, and their signaling pathways. Immunol Rev 202 (2004) 67-83
41. Varnavski A.N., Schlienger K., Bergelson J.M., Gao G.P., and Wilson J.M. Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector. Hum Gene Ther 14 (2003) 533-544
42. Zhong L., Granelli-Piperno A., Choi Y., and Steinman R.M. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 29 (1999) 964-972
43. Kumar P., Sulochana P., Nirmala G., Chandrashekar R., Haridattatreya M., and Satchidanandam V. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J Infect Dis 189 (2004) 880-891
44. Kumar P., Uchil P.D., and Sulochana P. Screening for T cell eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 148 (2003) 1569-1591
45. Jiang W., Jiang P., Li Y., Tang J., Wang X., and Ma S. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet. Immunol. Immunopathol. 113 (2006) C169-C180